LECAP Asset Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$709K Sell
4,655
-5,832
-56% -$972K 0.3% 140
2026
Q1
$2.2M Buy
10,487
+1,558
+17% +$392K 0.83% 17
2025
Q4
$2.54M Buy
+8,929
New +$2.79M 1.01% 4
2025
Q3
Sell
-1,678
Closed -$527K 374
2025
Q2
$527K Buy
+1,678
New +$484K 0.19% 198
2024
Q4
Sell
-4,560
Closed -$1.06M 387
2024
Q3
$1.06M Buy
4,560
+918
+25% +$189K 0.23% 159
2024
Q2
$735K Sell
3,642
-590
-14% -$106K 0.16% 215
2024
Q1
$725K Sell
4,232
-2,727
-39% -$509K 0.15% 225
2023
Q4
$1.51M Buy
+6,959
New +$1.19M 0.55% 54

Other funds holding PODD

LECAP Asset Management's PODD Position: Q2 2026 in Review

LECAP Asset Management reduced its Insulet (PODD) stake by 56% in Q2 2026, selling an estimated $972K and leaving 4,655 shares worth $709K. The position accounts for 0.3% of the portfolio, ranked #140.

LECAP Asset Management first reported a position in PODD in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.54M in Q4 2025. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • LECAP Asset Management held 4,655 shares of Insulet worth $709K as of Q2 2026.
  • LECAP Asset Management sold 5,832 Insulet shares in Q2 2026, an estimated $972K.
  • Insulet made up 0.3% of LECAP Asset Management's portfolio in Q2 2026, its #140 holding.
  • LECAP Asset Management first reported a position in Insulet in Q4 2023 and has held it in 8 quarters since.
  • LECAP Asset Management's Insulet position peaked at $2.54M in Q4 2025.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on LECAP Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.